Effects of glucocorticoids in potentiating diuresis in heart failure patients with diuretic resistance.

Abstract:

:Diuretic resistance in heart failure is defined as a state in which diuretic response is diminished or lost before the therapeutic goal of relief from congestion has been reached. Diuretic resistance is very common and is associated with poor outcomes. Over the past decade, several new drugs and devices targeting decongestion and improvement in renal function in patients with heart failure have failed to show benefit in randomized clinical trials. Glucocorticoids had been used to manage diuretic resistance before the advent of loop diuretics. More recent evidence appears to confirm that glucocorticoids may also help to overcome resistance to loop diuretics. This review tries to summarize the available evidence and potential mechanisms related to glucocorticoid therapy in patients with heart failure and its effect on diuretic resistance.

journal_name

J Card Fail

authors

Liu C,Liu K

doi

10.1016/j.cardfail.2014.06.353

subject

Has Abstract

pub_date

2014-09-01 00:00:00

pages

625-9

issue

9

eissn

1071-9164

issn

1532-8414

pii

S1071-9164(14)00584-3

journal_volume

20

pub_type

杂志文章,评审
  • Can Biomarkers Provide Right Ventricular-Specific Prognostication in the Perioperative Setting?

    abstract::Since the introduction of biomarkers in the late 1980s, considerable research has been dedicated to their validation and application. As a result, many biomarkers are now commonly used in clinical practice. However, the role of biomarkers in the prediction of right ventricular failure (RVF) and in the prognostication ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2019.09.007

    authors: Jabagi H,Ruel M,Sun LY

    更新日期:2020-09-01 00:00:00

  • Age, but not sex, influences the measurement of ejection fraction in elderly patients hospitalized for heart failure.

    abstract:BACKGROUND:Current US and European guidelines recommend that ejection fraction (EF) be measured at least once in patients with congestive heart failure (CHF). However, it is not known how age and sex influence adherence to this recommendation. METHODS:We reviewed a national sample of Medicare patients discharged with ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2003.16

    authors: Lindenfeld J,Fiske KS,Stevens BR,Debuhr J,Havranek EP,Abrams FR

    更新日期:2003-04-01 00:00:00

  • Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy.

    abstract:BACKGROUND:The proinflammatory cytokines have been implicated in the pathogenesis of heart failure. Recent studies have shown that beta-adrenergic blockade can modulate cytokine production. This study investigates the different impact of different degrees of sympathetic antagonism on circulating levels of cytokines in ...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2004.07.006

    authors: Cinquegrana G,D'Aniello L,Landi M,Spinelli L,Grande G,De Prisco F,Petretta M

    更新日期:2005-04-01 00:00:00

  • Effect of exercise training on autonomic derangement and neurohumoral activation in chronic heart failure.

    abstract:BACKGROUND:In chronic heart failure (CHF), persistent autonomic derangement and neurohumoral activation cause structural end-organ damage, decrease exercise capacity, and reduce quality of life. Beneficial effects of pharmacotherapy and of exercise training in CHF have been documented at various functional and structur...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1016/j.cardfail.2006.12.006

    authors: Gademan MG,Swenne CA,Verwey HF,van der Laarse A,Maan AC,van de Vooren H,van Pelt J,van Exel HJ,Lucas CM,Cleuren GV,Somer S,Schalij MJ,van der Wall EE

    更新日期:2007-05-01 00:00:00

  • Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? The Heart Muscle Disease Study Group.

    abstract:BACKGROUND:Some controlled clinical trials showed a beneficial effect of beta-blockers on symptoms, exercise tolerance, and left ventricular function in dilated cardiomyopathy. The purpose of this study was to investigate if there are clinical variables at baseline that could predict a favorable response to long-term m...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/s1071-9164(96)80027-3

    authors: DiLenarda A,Gregori D,Sinagra G,Lardieri G,Perkan A,Pinamonti B,Salvatore L,Secoli G,Zecchin M,Camerini F

    更新日期:1996-06-01 00:00:00

  • Effect of acute β-blocker withholding on ventilatory efficiency in patients with advanced chronic heart failure.

    abstract:BACKGROUND:This is the first study to examine the effect of acute (24-hour) beta-blocker withholding on ventilatory efficiency in patients with advanced chronic heart failure (CHF) during maximal incremental treadmill cardiopulmonary exercise test. METHODS AND RESULTS:Seventeen CHF patients were studied either 3 hours...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2010.02.006

    authors: Laveneziana P,Agostoni P,Mignatti A,Mushtaq S,Colombo P,Sims D,Uriel N,Jorde UP

    更新日期:2010-07-01 00:00:00

  • Ranolazine Improves Right Ventricular Function in Patients With Precapillary Pulmonary Hypertension: Results From a Double-Blind, Randomized, Placebo-Controlled Trial.

    abstract:INTRODUCTION:A major outcome determinant in patients with precapillary pulmonary hypertension (PH) is right ventricular (RV) function. We studied the effect of ranolazine on RV function over 6 months using cardiovascular magnetic resonance (CMR) imaging in patients with precapillary PH (groups I, III, and IV). METHODS...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.10.006

    authors: Han Y,Forfia P,Vaidya A,Mazurek JA,Park MH,Ramani G,Chan SY,Waxman AB

    更新日期:2020-10-24 00:00:00

  • Inotropes and beta-blockers: is there a need for new guidelines?

    abstract::Beta-adrenergic blocking agents are standard treatment for patients with mild-to-moderate heart failure. When patients receiving beta-blockers decompensate they often need treatment with a positive inotropic agent. The beta-agonist dobutamine may not produce much increase in cardiac output during full-dose beta-blocke...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1054/jcaf.2001.26655

    authors: Bristow MR,Shakar SF,Linseman JV,Lowes BD

    更新日期:2001-06-01 00:00:00

  • Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.

    abstract:BACKGROUND:Right ventricular failure (RVF) after left ventricular assist device (LVAD) implantation results in significant morbidity and mortality. Preoperative parameters from transthoracic echocardiography (TTE) that predict RVF after LVAD implantation might identify patients in need of temporary or permanent right v...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2012.11.001

    authors: Raina A,Seetha Rammohan HR,Gertz ZM,Rame JE,Woo YJ,Kirkpatrick JN

    更新日期:2013-01-01 00:00:00

  • Prognostic Value of Left Atrial Functional Measures in Heart Failure With Reduced Ejection Fraction.

    abstract:BACKGROUND:The prognostic value of LA functional measures in heart failure patients with reduced ejection fraction (HFrEF) is unclear. Therefore, this study investigated the prognostic value of left atrial (LA) functional measures such as the left atrial emptying fraction (LAEF) and the minimal LA volume compared with ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2018.11.016

    authors: Modin D,Sengeløv M,Jørgensen PG,Olsen FJ,Bruun NE,Fritz-Hansen T,Andersen DM,Jensen JS,Biering-Sørensen T

    更新日期:2019-02-01 00:00:00

  • Effects of short-term forearm exercise training on resistance vessel endothelial function in normal subjects and patients with heart failure.

    abstract:BACKGROUND:Exercise training improves endothelium-dependent vasodilation in animals. This study was designed to determine whether forearm exercise training improves endothelium-dependent vasodilation in control subjects and patients with heart failure, a disease associated with abnormal endothelium-dependent vasodilati...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章

    doi:10.1016/s1071-9164(98)80006-7

    authors: Bank AJ,Shammas RA,Mullen K,Chuang PP

    更新日期:1998-09-01 00:00:00

  • The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure.

    abstract::Propionyl-L-carnitine (PLC) is a naturally occurring compound that has been considered for the treatment of congestive heart failure (CHF). The rationale for its use in this pathology is related to its effects on cardiac and skeletal muscle. Chronic treatment with PLC improves the contraction of isolated and aerobic p...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1016/s1071-9164(97)90018-x

    authors: Ferrari R,De Giuli F

    更新日期:1997-09-01 00:00:00

  • The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure.

    abstract:BACKGROUND:Aldosterone antagonists reduce morbidity and mortality in patients with severe heart failure, but the mechanisms responsible are not fully understood. Observations in animal models suggest that elevated levels of aldosterone promote oxidative stress and inflammation in the myocardium. It is unknown if these ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2005.08.005

    authors: Kotlyar E,Vita JA,Winter MR,Awtry EH,Siwik DA,Keaney JF Jr,Sawyer DB,Cupples LA,Colucci WS,Sam F

    更新日期:2006-03-01 00:00:00

  • Regional variations in physicians' attitudes and recommendations surrounding implantable cardioverter-defibrillators.

    abstract:INTRODUCTION:This study was designed to determine if physicians' attitudes and recommendations surrounding implantable cardioverter-defibrillators (ICDs) are regionally associated with ICD use. METHODS AND RESULTS:A national sample of 9969 members of the American College of Cardiology was surveyed electronically. Resp...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2010.11.009

    authors: Matlock DD,Kutner JS,Emsermann CB,Al-Khatib SM,Sanders GD,Dickinson LM,Rumsfeld JS,Davidson AJ,Crane LA,Masoudi FA

    更新日期:2011-04-01 00:00:00

  • Biomarker-guided therapies in heart failure: a forum for unified strategies.

    abstract::The complexity of standard medical treatment for heart failure is growing, and such therapy typically involves 5 or more different medications. Given these pressures, there is increasing interest in harnessing cardiovascular biomarkers for clinical application to more effectively guide diagnosis, risk stratification, ...

    journal_title:Journal of cardiac failure

    pub_type:

    doi:10.1016/j.cardfail.2013.05.012

    authors: Fiuzat M,O'Connor CM,Gueyffier F,Mascette AM,Geller NL,Mebazaa A,Voors AA,Adams KF,Piña IL,Neyses L,Muntendam P,Felker GM,Pitt B,Zannad F,Bristow MR

    更新日期:2013-08-01 00:00:00

  • Pulmonary hypertension and systemic hypotension as limitations to exercise in chronic heart failure.

    abstract::The authors have previously shown that the resistance ratio (RR) is increased in patients with congestive heart failure (CHF), and that the patients with the highest RRs have an increased mortality. The authors hypothesized that CHF patients with the lowest maximum oxygen consumption and the most impaired Weber functi...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/1071-9164(94)90005-1

    authors: Mabee SW,Metra M,Reed DE,Dei Cas L,Cody RJ

    更新日期:1994-10-01 00:00:00

  • Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic.

    abstract:BACKGROUND:Drug-related negative outcomes (DNOs) are health problems that patients experience due to drug use or nonuse. Heart failure (HF) patients are at high risk of experiencing DNOs owing to polypharmacy, comorbidities, and age. METHODS AND RESULTS:Ninety-seven consecutive HF patients were enrolled and followed f...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2010.10.009

    authors: Gastelurrutia P,Benrimoj SI,Espejo J,Tuneu L,Mangues MA,Bayes-Genis A

    更新日期:2011-03-01 00:00:00

  • The role of coenzyme Q10 in the pathophysiology and therapy of experimental congestive heart failure in the dog.

    abstract:BACKGROUND:Coenzyme Q10 (CoQ10) is essential for ATP generation and has antioxidant properties. Decreased CoQ10 levels have been reported in human heart failure (CHF), but it remains unclear if this is a conserved feature of CHF. The objective of the study was to determine if tachycardia-induced CHF in the dog is assoc...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2000.8839

    authors: Harker-Murray AK,Tajik AJ,Ishikura F,Meyer D,Burnett JC,Redfield MM

    更新日期:2000-09-01 00:00:00

  • Differences in education, knowledge, self-management activities, and health outcomes for patients with heart failure cared for under the chronic disease model: the improving chronic illness care evaluation.

    abstract:BACKGROUND:The objective of this study was to determine whether participation in a quality improvement (QI) collaborative for heart failure (HF) was associated with better interpersonal aspects of care and health outcomes. METHODS AND RESULTS:We conducted a cross-sectional telephone survey of patients in 6 organizatio...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2005.03.010

    authors: Baker DW,Asch SM,Keesey JW,Brown JA,Chan KS,Joyce G,Keeler EB

    更新日期:2005-08-01 00:00:00

  • Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial.

    abstract:BACKGROUND:In patients with heart failure and preserved ejection fraction (HF-PEF) randomized in the Americas as part of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, treatment with spironolactone enhanced the risk of hyperkalemia but reduced the risk of hypoka...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.cardfail.2018.03.002

    authors: Desai AS,Liu J,Pfeffer MA,Claggett B,Fleg J,Lewis EF,McKinlay S,O'Meara E,Shah SJ,Sweitzer NK,Solomon S,Pitt B

    更新日期:2018-05-01 00:00:00

  • ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation.

    abstract:OBJECTIVES:There have been no published recommendations about staffing needs for a heart failure (HF) clinic or an office setting focused on heart transplant. The goal of this survey was to understand the current staffing environment of HF, transplant, and mechanical circulatory support device (MCSD) programs in the Un...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.cardfail.2011.04.001

    authors: Jessup M,Albert NM,Lanfear DE,Lindenfeld J,Massie BM,Walsh MN,Zucker MJ,ACCF Heart Failure and Transplant Committee.,AHA Heart Failure and Transplantation Committee.,Heart Failure Society of America.

    更新日期:2011-05-01 00:00:00

  • Treatment of heart failure according to William Stokes: the enchanted mercury.

    abstract:BACKGROUND:It was not until 1919 that the diuretic properties of mercury were observed in patients with syphilis; in the same year the beneficial effects of mercurial diuretics were shown in a patient with severe rheumatic heart disease and anasarca. However, mercury had been used much earlier for the treatment of drop...

    journal_title:Journal of cardiac failure

    pub_type: 传,历史文章,杂志文章

    doi:10.1054/jcaf.2001.26564

    authors: Ventura HO,Mehra MR,Young JB

    更新日期:2001-09-01 00:00:00

  • Prolonged electrocardiogram QRS duration independently predicts long-term mortality in patients hospitalized for heart failure with preserved systolic function.

    abstract:BACKGROUND:Prolonged electrocardiogram (ECG) QRS duration (>or=120 ms) is a risk factor for death in systolic heart failure, but its effects in heart failure with preserved systolic function (HFPSF) have not been extensively studied. We hypothesized that prolonged ECG QRS duration would independently predict long-term ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.cardfail.2009.02.002

    authors: Hummel SL,Skorcz S,Koelling TM

    更新日期:2009-09-01 00:00:00

  • Polymorphisms of matrix metalloproteinases in systolic heart failure: role on disease susceptibility, phenotypic characteristics, and prognosis.

    abstract:BACKGROUND:The role of matrix metalloproteinases (MMPs) polymorphisms on heart failure (HF) susceptibility, phenotypic characteristics, and prognosis has been poorly explored. METHODS AND RESULTS:We studied 313 HF patients with left ventricular systolic dysfunction and 367 healthy control subjects. Genotyping of MMP-1...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2010.09.017

    authors: Velho FM,Cohen CR,Santos KG,Silvello D,Martinelli N,Biolo A,Clausell N,Rohde LE

    更新日期:2011-02-01 00:00:00

  • Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome.

    abstract:BACKGROUND:Cardiac involvement in Churg-Strauss vasculitis worsens the prognosis. Early detection is, therefore, warranted. Cardiac magnetic resonance (CMR) can visualize various forms of inflammatory changes in the myocardium. We tested whether CMR could elucidate cardiac damage in patients with biopsy-proven Churg-St...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2008.07.227

    authors: Wassmuth R,Göbel U,Natusch A,Schneider W,Kettritz R,Dietz R,Luft FC,Schulz-Menger J

    更新日期:2008-12-01 00:00:00

  • Predictors and outcomes of "super-response" to cardiac resynchronization therapy.

    abstract:BACKGROUND:Cardiac resynchronization therapy (CRT) has been shown to improve heart failure (HF) symptoms and survival. We hypothesized that a greater improvement in left-ventricular ejection fraction (LVEF) after CRT is associated with greater survival benefit. METHODS AND RESULTS:In 693 patients across 2 internationa...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.cardfail.2014.03.001

    authors: Killu AM,Grupper A,Friedman PA,Powell BD,Asirvatham SJ,Espinosa RE,Luria D,Rozen G,Buber J,Lee YH,Webster T,Brooke KL,Hodge DO,Wiste HJ,Glikson M,Cha YM

    更新日期:2014-06-01 00:00:00

  • Hemodynamic ranges during daily activities and exercise testing in patients with pulmonary arterial hypertension.

    abstract:BACKGROUND:In patients with pulmonary arterial hypertension (PAH) the relationship between hemodynamic impairment experienced during daily activity and that during exercise testing is not known. METHODS AND RESULTS:Ten PAH patients received an implantable hemodynamic monitor that continuously recorded and stored right...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2014.04.019

    authors: Kjellström B,Frantz RP,Benza RL,Bennett T,Bourge RC,McGoon MD

    更新日期:2014-07-01 00:00:00

  • Impact of 6 months of therapy with carvedilol on muscle sympathetic nerve activity in heart failure patients.

    abstract:BACKGROUND:The long-term effects of carvedilol on muscle sympathetic nerve activity (MSNA) and muscle blood flow at rest and exercise in patients with chronic heart failure (CHF) remain unknown. METHODS AND RESULTS:Twenty-six patients (New York Heart Association class II-III) were randomized to carvedilol or placebo. ...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2004.03.006

    authors: De Matos LD,Gardenghi G,Rondon MU,Soufen HN,Tirone AP,Barretto AC,Brum PC,Middlekauff HR,Negrão CE

    更新日期:2004-12-01 00:00:00

  • The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.

    abstract:BACKGROUND:The role of anticoagulation in patients with chronic heart failure has long been an area of interest and controversy. Traditionally the goal of anticoagulation has been to prevent embolic events, but recent trials also demonstrated that oral anticoagulation also prevents vascular events in patients with prio...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.cardfail.2004.02.006

    authors: Massie BM,Krol WF,Ammon SE,Armstrong PW,Cleland JG,Collins JF,Ezekowitz M,Jafri SM,O'Connor CM,Packer M,Schulman KA,Teo K,Warren S

    更新日期:2004-04-01 00:00:00

  • Quality of life assessment for acute heart failure patients from emergency department presentation through 30 days after discharge: a pilot study with the Kansas City Cardiomyopathy Questionnaire.

    abstract:BACKGROUND:There are no well validated patient-reported disease status instruments for acute heart failure (HF). We assessed the feasibility of using the Kansas City Cardiomyopathy Questionnaire (KCCQ) during acute heart failure hospitalization, and the association of acute changes with 30-day readmission. METHODS AND...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2013.11.010

    authors: Sauser K,Spertus JA,Pierchala L,Davis E,Pang PS

    更新日期:2014-01-01 00:00:00